Xumei Li
Overview
Explore the profile of Xumei Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Jian J, Zhang A, Xiang J, Huang J, Chen Y
Sci Rep
. 2024 Aug;
14(1):18125.
PMID: 39103463
Papillary thyroid carcinoma (PTC) is the most common pathological type of thyroid cancer (THCA) and shows a better prognosis than other types. However, further research is needed to determine the...
2.
Yang X, Wu Q, Jian J, Qu Y, Qiang Y, Li X, et al.
Sci Rep
. 2024 Jul;
14(1):17608.
PMID: 39080388
The available data on epidemiology and prognostic factors of female patients with breast cancer aged 85 years and older in the USA are limited, especially regarding molecular-level heterogeneity. Relevant data...
3.
Yang P, Dai D, Li Q, Zhan H, Li X, Lu X, et al.
Zhejiang Da Xue Xue Bao Yi Xue Ban
. 2024 Jul;
53(5):615-622.
PMID: 39034149
Objectives: To investigate the incidence and influencing factors of allergic reactions to cephalosporins. Methods: A cross-sectional study of 29 medical institutions in Zhejiang Province was conducted from April 2021 to...
4.
Li X, Li X, Liu G, Zhou L, Liu Y, Dou T, et al.
J Cancer
. 2023 Oct;
14(15):2759-2770.
PMID: 37781083
Acidic leucine rich nuclear phosphoprotein-32A (ANP32A) protein has a variety of functions, such as regulating cell differentiation, influencing cell apoptosis and cell cycle progression. Our previous study demonstrated that high...
5.
Zhan X, Bao S, Li X, Zhou S, Dahar M, Lin N, et al.
Biopharm Drug Dispos
. 2023 Jan;
44(2):165-174.
PMID: 36649539
Osimertinib is a highly selective third-generation irreversible inhibitor of epidermal growth factor receptor mutant, which can be utilized to treat non-small cell lung cancer. As the substrate of cytochrome P450...
6.
Lin B, Hu Y, Xu P, Xu T, Chen C, He L, et al.
Front Public Health
. 2022 Aug;
10:967311.
PMID: 36033811
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed...
7.
Yuan X, Wang J, Yang S, Gao M, Cao L, Li X, et al.
Int J Endocrinol
. 2022 Apr;
2022:6999907.
PMID: 35371260
The question of whether or not intermittent fasting diets improve the clinical indicators of glycolipid metabolism remains unclear. This study systematically reviewed the relevant clinical trials to evaluate the effects...
8.
Curcumol simultaneously induces both apoptosis and autophagy in human nasopharyngeal carcinoma cells
Wang J, Liu G, Li X, HuangFu M, Liu Y, Li X, et al.
Phytother Res
. 2021 Nov;
35(12):7004-7017.
PMID: 34750896
Autophagy is usually considered as a protective mechanism against cell death, and in the meantime, leads to cell injury even apoptosis. Apoptosis and autophagy are very closely connected and may...
9.
Guan X, Yu D, HuangFu M, Huang Z, Dou T, Liu Y, et al.
Biochem Pharmacol
. 2021 Aug;
192:114742.
PMID: 34428442
Metastasis is a major cause of recurrence and death in patients with EBV-positive Nasopharyngeal carcinoma (NPC). Previous reports documented that curcumol has both anti-cancer and anti-viral effects, but there is...
10.
Yu D, Liu H, Qin J, HuangFu M, Guan X, Li X, et al.
Oncol Lett
. 2021 Mar;
21(4):299.
PMID: 33732375
MicroRNA-30a-5p (miR-30a-5p), which functions as a tumor suppressor, has been reported to be downregulated in colorectal cancer (CRC) tissues and to be associated with cancer invasion. However, the detailed regulatory...